Methylation hotspots evidenced by deep sequencing in patients with facioscapulohumeral dystrophy and mosaicism

Objective To investigate the distribution of cytosine-guanine dinucleotide (CpG) sites with a variable level of DNA methylation of the D4Z4 macrosatellite element in patients with facioscapulohumeral dystrophy (FSHD). Methods By adapting bisulfite modification to deep sequencing, we performed a comprehensive analysis of D4Z4 methylation across D4Z4 repeats and adjacent 4qA sequence in DNA from patients with FSHD1, FSHD2, or mosaicism and controls. Results Using hierarchical clustering, we identified clusters with different levels of methylation and separated, thereby the different groups of samples (controls, FSHD1, and FSHD2) based on their respective level of methylation. We further show that deep sequencing–based methylation analysis discriminates mosaic cases for which methylation changes have never been evaluated previously. Conclusions Altogether, our approach offers a new high throughput tool for estimation of the D4Z4 methylation level in the different subcategories of patients having FSHD. This methodology allows for a comprehensive and discriminative analysis of different regions along the macrosatellite repeat and identification of focal regions or CpG sites differentially methylated in patients with FSHD1 and FSHD2 but also complex cases such as those presenting mosaicism.

[1]  R. Tawil,et al.  Facioscapulohumeral Dystrophy , 2016, Current Neurology and Neuroscience Reports.

[2]  Albert David,et al.  Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy , 2019, Journal of Medical Genetics.

[3]  Shifeng Xue,et al.  SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite , 2019, Nucleic acids research.

[4]  F. Puppo,et al.  Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy , 2017, Human mutation.

[5]  Ryan L. Collins,et al.  SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome , 2017, Nature Genetics.

[6]  Asif Javed,et al.  De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development , 2017, Nature Genetics.

[7]  F. Puppo,et al.  Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report , 2016, BMC Medical Genetics.

[8]  E. Ricci,et al.  Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2 , 2016, Journal of Medical Genetics.

[9]  G. Ast,et al.  The alternative role of DNA methylation in splicing regulation. , 2015, Trends in genetics : TIG.

[10]  O. King,et al.  Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy , 2015, Clinical Epigenetics.

[11]  Daniel G. Miller,et al.  Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. , 2015, Human molecular genetics.

[12]  O. King,et al.  Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing , 2014, Clinical Epigenetics.

[13]  A. Verbeek,et al.  Population-based incidence and prevalence of facioscapulohumeral dystrophy , 2014, Neurology.

[14]  F. Puppo,et al.  Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers , 2014, Neurology.

[15]  J. Mathers,et al.  Comparison of Methods for Quantification of Global DNA Methylation in Human Cells and Tissues , 2013, PloS one.

[16]  M. Kyba,et al.  A focal domain of extreme demethylation within D4Z4 in FSHD2 , 2013, Neurology.

[17]  Daniel G. Miller,et al.  Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2 , 2012, Nature Genetics.

[18]  L. Salviati,et al.  Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity , 2011, Journal of Medical Genetics.

[19]  J. Pouget,et al.  Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy , 2011, Annals of neurology.

[20]  M. Tarnopolsky,et al.  Clinical features of facioscapulohumeral muscular dystrophy 2 , 2010, Neurology.

[21]  R. Frants,et al.  Common epigenetic changes of D4Z4 in contraction‐dependent and contraction‐independent FSHD , 2009, Human mutation.

[22]  J. Hewitt.  Faculty Opinions recommendation of Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). , 2009 .

[23]  Rune R. Frants,et al.  Specific Loss of Histone H3 Lysine 9 Trimethylation and HP1γ/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD) , 2009, PLoS genetics.

[24]  G. Fourel,et al.  Global analysis of DNA methylation and transcription of human repetitive sequences. , 2009, Epigenetics.

[25]  J. Jurka,et al.  Repetitive sequences in complex genomes: structure and evolution. , 2007, Annual review of genomics and human genetics.

[26]  Michael Q. Zhang,et al.  Large-scale structure of genomic methylation patterns. , 2005, Genome research.

[27]  Thomas Lengauer,et al.  BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing , 2005, Bioinform..

[28]  E. Ricci,et al.  Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy , 2005, Annals of neurology.

[29]  T. Bruxner,et al.  An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. V. Ommen,et al.  Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy , 2003, Nature Genetics.

[31]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[32]  R. Lyle,et al.  The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. , 1995, Genomics.

[33]  Wolfgang Stephan,et al.  The evolutionary dynamics of repetitive DNA in eukaryotes , 1994, Nature.

[34]  C. Wijmenga,et al.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy , 1992, Nature genetics.

[35]  J. Farnham,et al.  The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD). , 1992, American journal of human genetics.

[36]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Sandkuijl,et al.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. , 2000, American journal of human genetics.

[38]  M. Pericak-Vance,et al.  Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. , 1992, American journal of human genetics.